[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90975]], camposKey:0039-2499 2025-10-01 Targeting Innate Immune Memory for Stroke Prevention and Prognosis30953098, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90976]], camposKey:0039-2499 2025-09-01 Changes in Infarct Volume and Cerebral Edema After Mechanical Thrombectomy in Patients With Stroke Randomized to ApTOLL or Placebo: A Secondary Analysis of APRIL Trial24222430, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90977]], camposKey:0213-4853 2025-07-01 Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study Incidencia y pronóstico del ictus minor y ataque isquémico transitorio de alto riesgo en Nordictus. Estudio IMMINENT489498, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90978]], camposKey:0028-3878 2025-06-26 General vs Nongeneral Anesthesia for Endovascular Thrombectomy in Patients with Large Core Strokes: A Prespecified Secondary Analysis of SELECT2 Trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90979]], camposKey:0028-4793 2025-04-10 Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels13741384, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90980]], camposKey:0364-5134 2025-04-01 Critical Care Decisions After Large Core Cerebral Infarctions: A Secondary Analysis From the SELECT2 Trial698708, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90981]], camposKey:0213-4853 2025-03-01 Selection of patients for percutaneous closure in nonlacunar cryptogenic stroke associated with patent foramen ovale. Data from the NORDICTUS cooperative registry Selección de pacientes para cierre percutáneo en el ictus isquémico no lacunar criptogénico asociado a foramen oval permeable. Datos del registro cooperativo NORDICTUS139149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90982]], camposKey:2077-0383 2025-02-01 Clinical and Economic Impact of a First Major Bleeding Event in Non-Anticoagulated Patients in Spain: A 3-Year Retrospective Observational Cohort Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90983]], camposKey:1759-8478 2025-01-17 Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: A secondary analysis of the SELECT2 randomized trial120127, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90985]], camposKey:0364-5134 2025-01-01 Association of Reperfusion and Procedural Characteristics with Endovascular Thrombectomy Outcomes in Large Core Stroke: Sub-Analysis from the SELECT2 Trial175184, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90984]], camposKey:1351-5101 2025-01-01 Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93968]], camposKey:0213-4853 2025-01-01 Selección de pacientes para cierre percutáneo en el ictus isquémico no lacunar criptogénico asociado a foramen oval permeable. Datos del registro cooperativo NORDICTUS139149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90299]], camposKey:2044-4052 2024-12-01 Effect of a diabetes-specific formula in non-diabetic inpatients with stroke: a randomized controlled trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90986]], camposKey:1474-4422 2024-12-01 Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial12051213, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90376]], camposKey:2045-2322 2024-12-01 NEIVATECH pilot study: immersive virtual reality training in older amblyopic children with non-compliance or non-response to patching00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90987]], camposKey:0364-5134 2024-11-01 Anticoagulation Use and Endovascular Thrombectomy in Patients with Large Core Stroke: A Secondary Analysis of the SELECT2 Trial887894, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90383]], camposKey:2077-0383 2024-10-01 Randomized Controlled Trial to Assess the Feasibility of a Novel Clinical Decision Support System Based on the Automatic Generation of Alerts through Remote Patient Monitoring00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90988]], camposKey:0039-2499 2024-10-01 Sex-Stratified Genome-Wide Association Study in the Spanish Population Identifies a Novel Locus for Lacunar Stroke24622471, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90989]], camposKey:1474-4422 2024-08-01 Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial775786, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90990]], camposKey:2077-0383 2024-07-01 Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90991]], camposKey:0140-6736 2024-06-15 Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial25972605, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90992]], camposKey:1052-3057 2024-06-01 Pathology-based brain arterial disease phenotypes and their radiographic correlates00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90993]], camposKey:0028-4793 2024-05-09 Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size16771689, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90994]], camposKey:2168-6149 2024-04-08 Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients with Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial327335, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90995]], camposKey:1538-7933 2024-04-01 A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment936950, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90996]], camposKey:0098-7484 2024-03-05 Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles750763, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90997]], camposKey:2077-0383 2024-03-01 Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90998]], camposKey:0140-6736 2024-02-24 Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial731740, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89188]], camposKey:1052-3057 2024-01-01 A systematic review of the socioeconomic impact of mechanical thrombectomy for acute ischemic stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=91000]], camposKey:1530-6550 2024-01-01 Embolic Events in Infective Endocarditis: A Comprehensive Review00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=91001]], camposKey:0213-4853 2024-01-01 Influence of dehydration on collateral circulation and clinical outcome after endovascular therapy in patients with acute ischemic stroke Deshidratación, circulación colateral y pronóstico funcional en pacientes con ictus isquémico tratados mediante trombectomía mecánica00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=96231]], camposKey:2045-2322 2024-01-01 NEIVATECH pilot study: immersive virtual reality training in older amblyopic children with non-compliance or non-response to patching00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90999]], camposKey:0882-0538 2024-01-01 Pilot Study Assessing the Safety and Acceptance of a Novel Virtual Reality System to Improve Visual Function394399, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=79776]], camposKey:0165-5701 2023-11-01 Randomised placebo-controlled clinical trial evaluating the impact of a new visual rehabilitation program on neuroadaptation in patients implanted with trifocal intraocular lenses40354053, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80393]], camposKey:2168-6149 2023-08-14 Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial779788, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80394]], camposKey:1591-0199 2023-08-01 Neutrophil¿Lymphocyte ratio is associated with poor clinical outcome after mechanical thrombectomy in stroke in patients with COVID-19386392, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80395]], camposKey:2077-0383 2023-07-01 Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80396]], camposKey:0033-8419 2023-04-01 Thrombectomy versus Medical Management for Isolated Anterior Cerebral Artery Stroke: An International Multicenter Registry Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75471]], camposKey:1051-2284 2023-03-01 Intracranial atherosclerotic plaque enhancement and long-term risk of future strokes: A prospective, longitudinal study289301, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75472]], camposKey:2168-6149 2023-02-13 Association of Endovascular Thrombectomy vs Medical Management with Functional and Safety Outcomes in Patients Treated beyond 24 Hours of Last Known Well: The SELECT Late Study172182, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75408]], camposKey:1661-7827 2023-02-01 Randomized Controlled Trial Evaluating the Benefit of a Novel Clinical Decision Support System for the Management of COVID-19 Patients in Home Quarantine: A Study Protocol00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75409]], camposKey:2222-3959 2023-01-18 Visual perception alterations in COVID-19: a preliminary study19, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80398]], camposKey:1663-4365 2023-01-01 Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80397]], camposKey:1747-4930 2023-01-01 Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80399]], camposKey:0028-4793 2023-01-01 Trial of Endovascular Thrombectomy for Large Ischemic Strokes.12591271, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69370]], camposKey:1471-2415 2022-12-01 Study protocol for a randomized controlled trial of the NEIVATECH virtual reality system to improve visual function in children with anisometropic amblyopia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75473]], camposKey:1474-4422 2022-10-01 Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders899910, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75474]], camposKey:1664-2295 2022-09-27 Editorial: Understanding stroke recovery to improve outcomes: From acute care to chronic rehabilitation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69372]], camposKey:2396-9873 2022-09-01 European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease34, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69371]], camposKey:0364-5134 2022-09-01 Thrombectomy versus Medical Management in Mild Strokes due to Large Vessel Occlusion: Exploratory Analysis from the EXTEND-IA Trials and a Pooled International Cohort364378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69373]], camposKey:2297-055X 2022-07-08 A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69374]], camposKey:2297-055X 2022-07-04 Blood-Based Biomarkers to Search for Atrial Fibrillation in High-Risk Asymptomatic Individuals and Cryptogenic Stroke Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69375]], camposKey:0006-8950 2022-07-01 Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke23942406, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69376]], camposKey:0148-396X 2022-06-01 Characteristics of a COVID-19 Cohort With Large Vessel Occlusion: A Multicenter International Study725733, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68297]], camposKey:2352-9067 2022-04-01 Proteins and pathways in atrial fibrillation and atrial cardiomyopathy underlying cryptogenic stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66666]], camposKey:0213-4853 2022-01-01 Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology Dislipidemias y prevención del ictus: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología6172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69378]], camposKey:0910-8327 2022-01-01 Intensive 90-day textile wearable Holter monitoring: an alternative to detect paroxysmal atrial fibrillation in selected patients with cryptogenic stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69377]], camposKey:1351-5101 2022-01-01 International controlled study of revascularization and outcomes following COVID-positive mechanical thrombectomy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69379]], camposKey:2059-8688 2021-12-01 Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic542552, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66667]], camposKey:0039-2499 2021-12-01 Infarct core growth velocity: Characterizing the hot penumbra without looking at it40074009, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69380]], camposKey:1471-2377 2021-12-01 Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66668]], camposKey:1868-4483 2021-10-01 Predicting Atrial Fibrillation with High Risk of Embolization with Atrial Strain and NT-proBNP735741, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66670]], camposKey:0006-8950 2021-08-01 Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma24162426, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66671]], camposKey:1747-4930 2021-07-01 Global impact of COVID-19 on stroke care573584, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66839]], camposKey:0028-3878 2021-06-08 Global Impact of COVID-19 on Stroke Care and IV Thrombolysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66674]], camposKey:1747-4930 2021-06-01 Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry437447, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69382]], camposKey:1759-8478 2021-06-01 SELECTion criteria for large core trials: Dogma or data?500504, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66673]], camposKey:0303-8467 2021-06-01 Smart glasses evaluation during the COVID-19 pandemic: First-use on Neurointerventional procedures00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66676]], camposKey:1015-9770 2021-05-01 Impact of Mediterranean Diet prior to Stroke on the Prognosis of Patients Undergoing Endovascular Treatment303309, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69383]], camposKey:2162-3279 2021-04-01 Neurological symptoms in Covid-19 patients in the emergency department00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69384]], camposKey:2077-0383 2021-03-01 Circulating AQP4 levels in patients with cerebral amyloid angiopathy-associated intracerebral hemorrhage115, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66677]], camposKey:1351-5101 2021-02-01 B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke540547, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69385]], camposKey:2164-2591 2021-02-01 Multitasking compensatory saccadic training program for hemianopia patients: A new approach with 3-dimensional real-world objects119, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69386]], camposKey:2227-9059 2021-01-01 Comparison of plasma lipoprotein composition and function in cerebral amyloid angiopathy and alzheimer¿s disease114, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66679]], camposKey:0039-2499 2021-01-01 Delayed Neurological Improvement after Full Endovascular Reperfusion in Acute Anterior Circulation Ischemic Stroke22102217, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64747]], camposKey:0210-0010 2021-01-01 Efecto del tratamiento con benzodiacepinas en el pronóstico hospitalario de la enfermedad por coronavirus 2019201209, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65165]], camposKey:1177-5467 2021-01-01 Oct variability prevents their use as robust biomarkers in multiple sclerosis20252036, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68442]], camposKey:2076-3425 2021-01-01 Preliminary evaluation of the clinical benefit of a novel visual rehabilitation program in patients implanted with trifocal diffractive intraocular lenses: A blinded randomized placebo¿controlled clinical trial11810, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64746]], camposKey:0213-4853 2021-01-01 Prevención de ictus en pacientes con diabetes mellitus tipo 2 o prediabetes. Recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64748]], camposKey:0213-4853 2021-01-01 Recomendaciones de la Sociedad Española de Neurología para la prevención del ictus. Actuación sobre los hábitos de vida y la contaminación atmosférica00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64559]], camposKey:0210-0010 2021-01-01 Rehabilitación integral postictus: efectos a largo plazo y factores socioambientales condicionantes del acceso19, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69381]], camposKey:2077-0383 2021-01-01 Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66681]], camposKey:1591-0199 2021-01-01 Safety and feasibility of transradial use of 8F balloon guide catheter Flowgate2 for endovascular thrombectomy in acute ischemic stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66680]], camposKey:0039-2499 2021-01-01 SARS-CoV-2 and Stroke Characteristics: A Report from the Multinational COVID-19 Stroke Study Group00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66682]], camposKey:1079-5006 2021-01-01 Sex-specific protective effects of APOE ¿2 on cognitive performance4149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66678]], camposKey:1759-8478 2021-01-01 Thrombectomy for secondary distal, medium vessel occlusions of the posterior circulation: Seeking complete reperfusion00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65727]], camposKey:0022-510X 2020-12-15 Anosmia is associated with lower in-hospital mortality in COVID-1900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69388]], camposKey:2045-2322 2020-12-01 Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69387]], camposKey:2045-2322 2020-12-01 Quantified ischemic core¿s radiological hypodensity and risk of parenchymal hematoma in > 4.5 h-window stroke thrombectomy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77492]], camposKey:2524-3489 2020-12-01 Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69389]], camposKey:1664-2295 2020-11-26 Oral Anticoagulation and Risk of Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Mechanical Thrombectomy: Data From the Nordictus Registry00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69390]], camposKey:0140-6736 2020-11-14 Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data15741584, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66683]], camposKey:0021-9150 2020-11-01 The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: Subclinical cervico-cerebral stenosis and middle cerebral artery pulsatility index as predictors of long-term incident cognitive impairment104109, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66684]], camposKey:1747-4930 2020-10-01 Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain755762, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65733]], camposKey:0017-8748 2020-09-01 Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients16641672, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66685]], camposKey:1351-5101 2020-08-01 Large vessel occlusion is independently associated with atrial fibrillation detection16181624, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65735]], camposKey:1129-2369 2020-07-29 Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: A retrospective cohort study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66686]], camposKey:0213-4853 2020-05-01 Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey ¿Va a cambiar la neurología tras la pandemia de COVID-19 en los próximos 5 años? Estudio de enfoque mediante informadores clave252257, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66687]], camposKey:0340-5354 2020-03-01 Comment on the article ¿Symptomatic carotid near-occlusion causes a high risk of recurrent ipsilateral ischemic stroke¿ by Gu et al.849851, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58205]], camposKey:0039-2499 2020-01-01 Brain Atrophy and the Risk of Futile Endovascular Reperfusion in Acute Ischemic Stroke15141521, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66688]], camposKey:0039-2499 2020-01-01 Early Neurological Change after Ischemic Stroke Is Associated with 90-Day Outcome132141, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66690]], camposKey:1351-5101 2020-01-01 Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61691]], camposKey:1664-2295 2020-01-01 Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66689]], camposKey:0213-4853 2020-01-01 Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance Inhibidores de la proproteína convertasa subtilisina/kexina tipo 9 (iPCSK9) en la prevención secundaria de episodios vasculares en pacientes con ictus isquémico: Documento de consenso y aplicaciones prácticas00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68441]], camposKey:2077-0383 2020-01-01 Stimuli characteristics and psychophysical requirements for visual training in amblyopia: A narrative review39850, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59778]], camposKey:2090-004X 2020-01-01 The Potential of Virtual Reality for Inducing Neuroplasticity in Children with Amblyopia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66691]], camposKey:2287-6391 2020-01-01 The value of transcranial doppler sonography in hyperperfusion syndrome after carotid artery stenting: A nationwide prospective study254257, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66692]], camposKey:1387-2877 2020-01-01 Third Ventricle Width Assessed by Transcranial Sonography as Predictor of Long-Term Cognitive Impairment741749, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52803]], camposKey:1743-0003 2020-01-01 Visual processing speed in hemianopia patients secondary to acquired brain injury: a new assessment methodology00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69306]], camposKey:0039-2499 2019-08-01 Sphenopalatine Ganglion Stimulation to Augment Cerebral Blood Flow: A Randomized, Sham-Controlled Trial21082117, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43062]], camposKey:0140-6736 2019-07-20 An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial219229, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41778]], camposKey:0140-6736 2019-07-13 Extending thrombolysis to 4·5¿9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data139147, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41780]], camposKey:1015-9770 2019-07-01 Age- and sex-specific risk profiles and in-hospital mortality in 13,932 Spanish stroke patients151164, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41779]], camposKey:1015-9770 2019-07-01 Relevance of collaterals for the success of neuroprotective therapies in acute ischemic stroke: Insights from the randomized URICO-ICTUS Trial171177, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69307]], camposKey:2168-6149 2019-06-01 Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial641649, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41781]], camposKey:1936-8798 2019-05-13 Clinical Predictors of Hyperperfusion Syndrome Following Carotid Stenting: Results From a National Prospective Multicenter Study873882, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43063]], camposKey:1868-4483 2019-04-15 The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism204215, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43064]], camposKey:0021-9150 2019-03-01 The Barcelona-Asymptomatic Intracranial Atherosclerosis study: Subclinical intracranial atherosclerosis as predictor of long-term vascular events132136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74235]], camposKey:1135-5727 2019-01-01 Análisis de factores asociados a la recuperación integral de pacientes de ictus al alta de hospital de agudos00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43553]], camposKey:2072-6643 2019-01-01 Influence of hyperglycemia associated with enteral nutrition on mortality in patients with stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41782]], camposKey:1747-4930 2019-01-01 Intracranial arterial wall imaging: Techniques, clinical applicability, and future perspectives00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43065]], camposKey:1474-4422 2019-01-01 Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data4655, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43445]], camposKey:0028-3878 2019-01-01 Validation of a clinical-genetics score to predict hemorrhagic transformations after rtPA851863, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43066]], camposKey:1474-4422 2018-12-01 Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial10531060, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43067]], camposKey:0014-2565 2018-10-01 Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study Factores asociados al mal control de la anticoagulación con antivitamina K en pacientes con fibrilación auricular no valvular atendidos en consultas de Medicina Interna y Neurología. Estudio ALADIN327335, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41784]], camposKey:1474-4422 2018-10-01 Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data895904, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41783]], camposKey:0271-678X 2018-10-01 Relative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME18391847, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70952]], camposKey:0271-678X 2018-10-01 Relative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME (vol 38, pg 1839, 2018)18491849, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43068]], camposKey:2287-6391 2018-05-01 Intracranial large artery disease of non-atherosclerotic origin: Recent progress and clinical implications208217, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41785]], camposKey:0899-9007 2018-04-01 Influence of a multidisciplinary protocol on nutritional status at diagnosis in amyotrophic lateral sclerosis6772, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43069]], camposKey:0167-5273 2018-01-15 Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry4550, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69310]], camposKey:0039-2499 2018-01-01 Atrial Dysfunction Markers Predicted AF in Elderly Cryptogenic Stroke Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41786]], camposKey:1474-4422 2018-01-01 Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data4753, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43907]], camposKey:0213-4853 2018-01-01 Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease Uso de la polipíldora cardiovascular en la prevención secundaria de la enfermedad cerebrovascular00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41787]], camposKey:0210-0010 2017-10-16 Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in internal medicine and neurology departments of Spain Perfil clínico y satisfacción con el tratamiento anticoagulante en pacientes con fibrilación auricular no valvular atendidos en consultas de medicina interna y neurología de España361367, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69309]], camposKey:0195-668X 2017-08-01 Rapid atrial rate and implantable loop recorders for embolic strokes of unknown source: report of more than 2-years follow up in a single centre165165, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41788]], camposKey:0039-2499 2017-05-01 GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke11471153, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41789]], camposKey:1474-4422 2017-05-01 Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial369376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41790]], camposKey:1052-3057 2017-02-01 Reported Prestroke Physical Activity Is Associated with Vascular Endothelial Growth Factor Expression and Good Outcomes after Stroke425430, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41793]], camposKey:1747-4930 2017-01-01 Collaterals 2016: Translating the collaterome around the globe338342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44183]], camposKey:0213-4853 2017-01-01 Criterios para la formación y capacitación en Neurorradiología Intervencionista-Neurointervencionismo, acordados por el Grupo Español de Neurorradiología Intervencionista (GENI), la Sociedad Española de Neurorradiología (SENR), el Grupo de Estudio de Enfermedades Cerebrovasculares (GEECV) de la Sociedad Española de Neurología (SEN) y el grupo experto en enfermedades vasculares de la Sociedad...00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41791]], camposKey:0022-3050 2017-01-01 Principles of precision medicine in stroke5461, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41792]], camposKey:1747-4930 2017-01-01 Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy377382, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41794]], camposKey:0213-4853 2016-11-01 Atypical presentation of a distal cerebral aneurysm: Location and outcome in a young woman Aneurisma intracraneal distal con presentación atípica, localización y evolución en una mujer joven641642, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41795]], camposKey:0033-8419 2016-06-01 Analysis of workflow and time to treatment and the effects on outcome in endovascular treatment of acute ischemic stroke: Results from the SWIFT PRIME randomized controlled trial888897, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69311]], camposKey:0039-2499 2016-02-01 Collateral Blood Flow and Inflammatory Markers in Intracranial Atherosclerosis: Angiography and Biomarker Correlates in the BIOSIS and SAMMPRIS Trials00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43070]], camposKey:1660-4431 2016-01-01 Biomarkers, Natural Course and Prognosis93108, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41796]], camposKey:1052-3057 2015-11-01 Metabolic Syndrome Predicts Refractoriness to Intravenous Thrombolysis in Acute Ischemic Stroke26052612, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69321]], camposKey:1352-4585 2015-09-01 Netrin-1: a new player in multiple sclerosis pathogenesis?734735, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69323]], camposKey:1747-4930 2015-04-01 Accuracy of transcranial duplex sonography, compared with CT angiography, for detection of intracranial arterial occlusions in acute stroke344344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69325]], camposKey:1747-4930 2015-04-01 Cerebral infarct core estimation using aspects on plain CT and perfusion CT: Interregional variability307307, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69324]], camposKey:1747-4930 2015-04-01 Temporal evolution of symptomatic intracranial atherosclerotic plaque post-contrast enhancement: A serial high-resolution MRI study319319, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69327]], camposKey:0039-2499 2015-02-01 Coexisting Cerebrovascular Disease and Risk of Occult Atrial Fibrillation in Patients With Embolic Stroke of Undetermined Source00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69326]], camposKey:0039-2499 2015-02-01 Outcome of Cervical Internal Carotid Artery Occlusions After Intravenous Thrombolysis in Acute Ischemic Stroke Patients With Tandem Occlusions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41797]], camposKey:1591-0199 2015-02-01 Severe cerebral vasospasm in chronic cocaine users during neurointerventional procedures: A report of two cases1922, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41798]], camposKey:0165-5728 2015-01-01 Improvement of fatigue in multiple sclerosis by physical exercise is associated to modulation of systemic interferon response811, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43298]], camposKey:0213-4853 2014-07-05 Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment Guía de actuación clínica en la hemorragia subaracnoidea. Sistemática diagnóstica y tratamiento353370, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41799]], camposKey:0197-4580 2014-05-01 Thalamic diffusion differences related to cognitive function in white matter lesions11031110, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41802]], camposKey:0021-9150 2014-03-01 Ankle-brachial index in screening for asymptomatic carotid and intracranial atherosclerosis7275, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41803]], camposKey:0213-4853 2014-03-01 Guidelines for the treatment of acute ischaemic stroke Guía para el tratamiento del infarto cerebral agudo102122, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41800]], camposKey:0001-6314 2014-03-01 Intravenous thrombolysis in ischemic stroke with unknown onset using CT perfusion178183, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41801]], camposKey:0021-9150 2014-03-01 Predictive value of ankle-brachial index and PAI-1 in symptomatic intracranial atherosclerotic disease recurrence186189, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41804]], camposKey:0210-0010 2014-02-21 Spontaneous resolution of dural arteriovenous fistula type IV Resolución espontánea de una fístula dural arteriovenosa tipo IV190191, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93963]], camposKey:0213-4853 2014-01-01 Análisis de recursos asistenciales para el ictus en España en 2012: ¿beneficios de la Estrategia del Ictus del Sistema Nacional de Salud?387396, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41814]], camposKey:0213-4853 2014-01-01 Analysis of stroke care resources in Spain in 2012: Have we benefitted from the Spanish Health System's stroke care strategy? Análisis de recursos asistenciales para el ictus en España en 2012: ¿beneficios de la Estrategia del Ictus del Sistema Nacional de Salud?387396, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69312]], camposKey:1015-9770 2014-01-01 Diffusion tensor imaging, intracranial vascular resistance and cognition in middle-aged asymptomatic subjects497497, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41806]], camposKey:0210-0010 2014-01-01 Endovascular treatment of critical basilar stenosis with a solitaire ® stent device: A first experience in our centre Tratamiento endovascular de una estenosis crítica basilar con dispositivo stent solitaire ®: Primera experiencia en nuestro centro118120, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41815]], camposKey:0213-4853 2014-01-01 Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico168183, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41813]], camposKey:0340-5354 2014-01-01 How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up16141621, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41805]], camposKey:2211-0348 2014-01-01 Immune reconstitution inflammatory syndrome and natalizumab-Is it possible before removing the drug?659661, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69313]], camposKey:1015-9770 2014-01-01 LONG-TERM OUTCOMES IN ASYMPTOMATIC INTRACRANIAL ATHEROSCLEROSIS (The Barcelona-AsIA study)8788, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41807]], camposKey:1759-8478 2014-01-01 Paraspinal arteriovenous malformation Onyx embolization via an Ascent balloon00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41810]], camposKey:1015-9770 2014-01-01 Prestroke physical activity is associated with good functional outcome and arterial recanalization after stroke due to a large vessel occlusion304311, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41808]], camposKey:0039-2499 2014-01-01 Relative cerebral blood volume as a marker of durable tissue-at-risk viability in hyperacute ischemic stroke113118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47404]], camposKey:0210-0010 2014-01-01 Resolución espontánea de una fístula dural arteriovenosa tipo IV190191, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41812]], camposKey:1474-4422 2014-01-01 Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): A randomised, double-blind phase 2b/3 trial453460, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41809]], camposKey:0271-678X 2014-01-01 Tract-specific fractional anisotropy predicts cognitive outcome in a community sample of middle-aged participants with white matter lesions861869, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93962]], camposKey:0210-0010 2014-01-01 Tratamiento endovascular de una estenosis crítica basilar con dispositivo stent Solitaire ®:: primera experiencia en nuestro centro118120, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41817]], camposKey:0021-9150 2013-10-01 Asymptomatic cervicocerebral atherosclerosis, intracranial vascular resistance and cognition: The AsIA-Neuropsychology Study330335, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41816]], camposKey:1015-9770 2013-10-01 Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors98105, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69338]], camposKey:0140-6736 2013-08-10 Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial507515, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69334]], camposKey:0195-668X 2013-08-01 Detection of paroxysmal atrial fibrillation by an implantable subcutaneous holter in patients with non-lacunar cryptogenic ischemic stroke746746, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41819]], camposKey:1351-5101 2013-07-01 Predictive value of brain and vascular imaging including intracranial vessels in transient ischaemic attack patients: External validation of the ABCD3-I score10881093, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41820]], camposKey:0213-4853 2013-07-01 The costs of stroke in Spain by aetiology: The CONOCES study protocol Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES332339, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41822]], camposKey:0213-4853 2013-05-01 Clinical practice guidelines in intracerebral haemorrhage Guías de actuación clínica en la hemorragia intracerebral236249, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41821]], camposKey:1351-5101 2013-05-01 Collateral circulation on perfusion-computed tomography-source images predicts the response to stroke intravenous thrombolysis795802, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41823]], camposKey:1015-9770 2013-02-01 Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts8188, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93958]], camposKey:0210-0010 2013-01-01 Alto rendimiento del holter implantable en la detección de fibrilación auricular paroxística oculta en pacientes con ictus criptogénico y sospecha de mecanismo embólico251257, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69332]], camposKey:1015-9770 2013-01-01 Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study: REGICOR, Intima-media thickness and ankle-arm index as predictors of asymptomatic cervicocerebral atherosclerosis163163, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41825]], camposKey:0028-4793 2013-01-01 Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease24922503, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69331]], camposKey:1015-9770 2013-01-01 Collateral circulation on Perfusion Computed Tomography Source Images correlates with hemodynamic abnormalities in PCT maps.185185, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41818]], camposKey:0210-0010 2013-01-01 High performance of an implantable Holter monitor in the detection of concealed paroxysmal atrial fibrillation in patients with cryptogenic stroke and a suspected embolic mechanism Alto rendimiento del holter implantable en la detección de fibrilación auricular paroxística oculta en pacientes con ictus criptogénico y sospecha de mecanismo embólico251257, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69333]], camposKey:1015-9770 2013-01-01 Optimisation of sample size calculation in thrombectomy trials using the natural history of proximal occlusions after i.v. thrombolysis failure1111, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41824]], camposKey:0022-3050 2013-01-01 Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study596603, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41826]], camposKey:0210-0010 2012-12-12 Transcallosa diaschisis: Report of a case of crossed aphasia Diasquisis transcallosa: A propósito de un caso de afasia cruzada700701, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69340]], camposKey:0210-0010 2012-12-01 Interhemispheric diaschisis: a case of crossed aphasia700701, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41827]], camposKey:0213-4853 2012-11-01 Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style Guía para el tratamiento preventivo del ictus isquémico y AIT (I). Actuación sobre los factores de riesgo y estilo de vida560574, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41828]], camposKey:0039-2499 2012-10-01 Biological signatures of asymptomatic extra- and intracranial atherosclerosis: The Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study27122719, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41829]], camposKey:1355-6177 2012-09-01 Deep versus periventricular white matter lesions and cognitive function in a community sample of middle-aged participants874885, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43299]], camposKey:1015-9770 2012-08-01 Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: A case-control study3137, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69341]], camposKey:0195-668X 2012-08-01 Subclinical atrial fibrillation: a missing link in the etiology of cryptogenic ischemic stroke?373373, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41831]], camposKey:0149-5992 2012-06-01 Response to comment on: Calleja et al. Insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke. Diabetes Care 2011;34: 2413-241700, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41832]], camposKey:0210-0010 2012-03-12 Perfusion computed tomography makes it possible to overcome important SITS-MOST exclusion criteria for the endovenous thrombolysis of cerebral infarction La tomografía computarizada de perfusión permite superar importantes criterios de exclusión SITS-MOST para la trombólisis endovenosa del infarto cerebral271276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69342]], camposKey:0210-0010 2012-03-01 Perfusion computed tomography makes it possible to overcome important SITS-MOST exclusion criteria for the endovenous thrombolysis of cerebral infarction271276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41833]], camposKey:0021-9150 2012-03-01 The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: Prevalence and risk factors221225, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41834]], camposKey:1015-9770 2012-02-01 Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: A comparison of prognostic risk scores182189, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93957]], camposKey:0210-0010 2012-01-01 Diasquisis transcallosa:: a propósito de un caso de afasia cruzada700701, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=18361]], camposKey:0210-0010 2012-01-01 La tomografía computarizada de perfusión permite superar importantes criterios de exclusión SITS-MOST para la trombólisis endovenosa del infarto cerebral271276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41835]], camposKey:0197-4580 2012-01-01 Structural brain changes and cognition in relation to markers of vascular dysfunction00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41837]], camposKey:0213-4853 2011-10-01 Health care resources for stroke patients in Spain, 2010: Analysis of a national survey by the Cerebrovascular Diseases Study Group Recursos asistenciales en ictus en España 2010: análisis de una encuesta nacional del Grupo de Estudio de Enfermedades Cerebrovasculares449454, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41839]], camposKey:0021-9150 2011-09-01 Lipoprotein-associated phospholipase A 2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease181187, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41840]], camposKey:0213-4853 2011-09-01 Stroke health care plan (ICTUS II. 2010) Plan de asistencia sanitaria al ICTUS II. 2010383396, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41838]], camposKey:0003-9942 2011-09-01 Stroke-related translational research11101123, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69352]], camposKey:0039-2499 2011-03-01 Final Results Of The Barcelona-ASymptomatic Intracranial Atherosclerosis (ASIA) Study: Prevalence And Risk Factors00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69349]], camposKey:0039-2499 2011-03-01 Prediction Of Very Early Stroke Or High-risk Stroke Mechanism In Patients With Transient Ischemic Attack From The Promapa Study. A Prospective Comparison Of Prognostic Risk Scores00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69351]], camposKey:0039-2499 2011-03-01 Safety And Efficacy Of Intravenous Thrombolysis Beyond 4.5 Hours In Acute Ischemic Stroke Patients Selected By Perfusion Computed Tomography00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69350]], camposKey:0039-2499 2011-03-01 Subclinical Extracranial Carotid And Peripheral Arterial Disease As Risk Factors For ASymptomatic Intracranial Atherosclerosis (ASIA) In The Barcelona-ASIA Study: The Relevance Of A Global Evaluation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41836]], camposKey:0149-5992 2011-01-01 Insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke24132417, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41841]], camposKey:0039-2499 2011-01-01 Intracranial atherosclerosis: Current concepts00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93954]], camposKey:0213-4853 2011-01-01 Plan de asistencia sanitaria al ICTUS II. 2010383396, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93955]], camposKey:0213-4853 2011-01-01 Recursos asistenciales en ictus en España 2010: análisis de una encuesta nacional del Grupo de Estudio de Enfermedades Cerebrovasculares449454, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44872]], camposKey:1471-2377 2011-01-01 The population-based Barcelona-Asymptomatic Intracranial Atherosclerosis Study (ASIA): Rationale and design00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41842]], camposKey:0213-4853 2010-10-01 Acute basilar artery thrombosis Trombosis aguda de la arteria basilar1823, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41843]], camposKey:0028-3878 2010-08-31 Spot sign and live-imaged dramatic intracerebral hematoma expansion00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69357]], camposKey:0039-2499 2010-04-01 Genotyping Recurrence Of Stroke (GRECOS) Project: Two Genes Involved in Hypoxia Responses and Blood Brain Barrier Function Are Associated With Vascular Recurrence in a Preliminary Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69358]], camposKey:0039-2499 2010-04-01 Metabolic Syndrome is Associated With the Asymptomatic Phase of Intracranial Atherosclerosis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93967]], camposKey:0213-4853 2010-01-01 Factores de riesgo vascular y rendimiento cognitivo en personas de 50 a 65 años422429, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93964]], camposKey:0213-4853 2010-01-01 Trombosis aguda de la arteria basilar1823, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41844]], camposKey:0213-4853 2010-01-01 Vascular risk factors and cognitive performance in patients 50 to 65 years-old Factores de riesgo vascular y rendimiento cognitivo en personas de 50 a 65 años422429, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41845]], camposKey:0210-5691 2009-11-01 Stroke units: The best treatment for stroke patients Unidades de ictus: el mejor tratamiento para los pacientes con ictus00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41846]], camposKey:0213-4853 2009-10-19 Necessary components in the hospitals that attend patients with stroke: Results of a survey of Spanish experts Componentes necesarios en los hospitales que atienden a pacientes con ictus: Resultados de una encuesta de expertos españoles373378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69360]], camposKey:1424-7860 2009-08-22 Impact of previous knowledge of warning symptoms on extra-hospitalary latencies in patients with acute stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41847]], camposKey:0340-5354 2009-08-01 Influence of direct admission to Comprehensive Stroke Centers on the outcome of acute stroke patients treated with intravenous thrombolysis12701276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70958]], camposKey:0213-4853 2009-07-01 Necessary components in the hospitals that attend patients with stroke: results of a survey of Spanish experts373378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69362]], camposKey:0039-2499 2009-04-01 Influence Of Antiplatelet Pre-treatment On The Risk Of Intracranial Haemorrhage In Acute Ischemic Stroke After Intravenous Thrombolysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41849]], camposKey:0039-2499 2009-04-01 Response to letter by tsivgoulis et al00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69361]], camposKey:0039-2499 2009-04-01 The Population-based Asymptomatic Intracranial Atherosclerosis (BNM-ASIA) Study: Design And First Results.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41850]], camposKey:0039-2499 2009-02-01 The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men344349, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41851]], camposKey:1015-9770 2009-01-01 C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses95102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93956]], camposKey:0025-7753 2009-01-01 Impacto pronóstico del tiempo y el grado de recanalización arterial tras trombólisis con activador tisular del plasminógeno en pacientes con oclusión aguda de la arteria cerebral media609615, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41848]], camposKey:0025-7753 2009-01-01 Prognostic impact of time-point and degree of arterial recanalization of acute middle cerebral artery occlusions after intravenous tPA administration Impacto pronóstico del tiempo y el grado de recanalización arterial tras trombólisis con activador tisular del plasminógeno en pacientes con oclusión aguda de la arteria cerebral media609615, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41852]], camposKey:0028-3878 2008-07-15 Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke190195, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70950]], camposKey:0213-4853 2008-07-01 Training and experience in stroke units337341, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69283]], camposKey:0025-7753 2008-06-28 Ateromatosis intracraneal141152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41854]], camposKey:0025-7753 2008-06-28 Intracranial atherosclerosis Ateromatosis intracraneal141152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41855]], camposKey:0039-2499 2008-05-01 Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis14561463, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41856]], camposKey:0039-2499 2008-04-01 Simvastatin reduces the association of NMDA receptors to lipid rafts: A cholesterol-mediated effect in neuroprotection12691275, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69284]], camposKey:0039-2499 2008-02-01 Associated factors and prognostic implications of delay in acute stroke unit admission703703, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69289]], camposKey:0039-2499 2008-02-01 C-reactive protein gene C1444T polymorphism is associated with an increased risk of further ischemic events in patients with symptomatic intracranial atherostenoses536536, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69287]], camposKey:0039-2499 2008-02-01 Impact of the metabolic syndrome on the temporal profile of arterial recanalization after thrombolysis for acute middle cerebral artery ischemic stroke598598, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69285]], camposKey:0039-2499 2008-02-01 Neuroprotection from stroke-induced excitotoxicity: Direct effect of statins on brain parenchyma mediated by inhibition of neuronal cholesterol synthesis678678, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69286]], camposKey:0039-2499 2008-02-01 Nitric oxide mediates proliferation of endothelial progenitor cells in human ischemic stroke617617, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69290]], camposKey:0039-2499 2008-02-01 The metabolic syndrome is associated with a higher resistance to i.v. thrombolysis for acute ischemic stroke in women than in men532532, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69288]], camposKey:0039-2499 2008-02-01 Transcranial duplex 24 hour-monitoring of acute MCA occlusions after i.v. t-PA administration: Prognostic impact of time-point and degree of arterial recanalization592593, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47399]], camposKey:0213-4853 2008-01-01 Aprendizaje y experiencia en las unidades de ictus337341, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41859]], camposKey:0278-0240 2008-01-01 Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment181188, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41858]], camposKey:1351-5101 2008-01-01 Body temperature and response to thrombolytic therapy in acute ischaemic stroke13841389, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41857]], camposKey:0028-3878 2008-01-01 Influence of the stroke code activation source on the outcome of acute ischemic stroke patients12381243, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41860]], camposKey:0039-2499 2007-10-01 The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome27592764, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41861]], camposKey:1015-9770 2007-08-01 Prognostic value of myocardial perfusion gated SPECT in patients with symptomatic intracranial large-artery atherosclerosis247254, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41862]], camposKey:0039-2499 2007-07-01 The metabolic syndrome and stroke: Potential treatment approaches21962203, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41863]], camposKey:0039-2499 2007-06-01 Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study18551859, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69293]], camposKey:0039-2499 2007-02-01 Endothelial progenitor cells mediate functional recovery in ischemic stroke518518, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69294]], camposKey:0039-2499 2007-02-01 Metabolic syndrome and resistance to intravenous thrombolysis in stroke patients with acute middle cerebral artery occlusion499500, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69291]], camposKey:0039-2499 2007-02-01 Molecular mechanisms of iron overload-related brain damage in patients with acute ischemic stroke and thrombolytic treatment568568, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69295]], camposKey:0039-2499 2007-02-01 Plasma MMP-9 and fibronectin levels confirm their value as powerful predictors of hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke: A multicenter prospective study463463, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69292]], camposKey:0039-2499 2007-02-01 VEGF, SDF-1 alpha, and active MMP-9 mediate proliferation of endothelial progenitor cells in human ischemic stroke519519, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41864]], camposKey:0001-6314 2007-01-01 C-reactive protein predicts further ischemic events in transient ischemic attack patients6066, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41865]], camposKey:0039-2499 2007-01-01 Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke9095, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69391]], camposKey:1471-2458 2007-01-01 Peripheral Arterial Disease Study (PERART): Prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43300]], camposKey:1092-8464 2007-01-01 The role of angiogenesis in damage and recovery from ischemic stroke205212, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41866]], camposKey:0028-3878 2006-07-01 Plasma D-dimer predicts poor outcome after acute intracerebral hemorrhage9498, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41867]], camposKey:0025-7753 2006-05-06 Usefulness of urgent combined carotid/transcranial ultrasound testing in early prognosis of TIA patients Efectividad del estudio ultrasonográfico precoz en el pronóstico a corto plazo de los pacientes con un accidente vascular cerebral isquémico transitorio647650, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41868]], camposKey:1015-9770 2006-05-01 Gene expression in cerebral ischemia: A new approach for neuroprotection3037, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41869]], camposKey:1351-5101 2006-04-01 Real-time monitoring of recanalization after intravenous thrombolysis for acute ischemic stroke [3]426427, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70951]], camposKey:0213-4853 2006-03-01 Survey on the current situation of the young neurologists in Spain: analysis of their current working stability and degree of social protection6879, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41870]], camposKey:0213-4853 2006-03-01 Survey on the current situation of the young neurologists in Spain: Analysis of their current working stability and degree of social protection Encuesta sobre la situación actual de los neurólogos jóvenes en España: Análisis de la estabilidad laboral y de la protectión social6879, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69297]], camposKey:0039-2499 2006-02-01 Hemorrhagic transformation is associated with hyperthermia in patients with acute stroke626626, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69296]], camposKey:0039-2499 2006-02-01 Influence of body temperature on the response to tissue plasminogen activator in acute ischemic stroke706706, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41871]], camposKey:0039-2499 2006-02-01 Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator425429, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93970]], camposKey:0025-7753 2006-01-01 Efectividad del estudio ultrasonográfico precoz en el pronóstico a corto plazo de los pacientes con un accidente vascular cerebral isquémico transitorio647650, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93959]], camposKey:0213-4853 2006-01-01 Encuesta sobre la situación actual de los neurólogos jóvenes en España: análisis de la estabilidad laboral y de la protección social6879, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41872]], camposKey:1015-9770 2005-12-01 Basic mechanisms in intracranial large-artery atherosclerosis: Advances and challenges7583, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41873]], camposKey:0039-2499 2005-08-01 Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients17051709, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41874]], camposKey:0039-2499 2005-07-01 A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke14151420, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41875]], camposKey:0039-2499 2005-07-01 Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke14521456, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41876]], camposKey:0039-2499 2005-06-01 Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: Associated factors12011206, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41877]], camposKey:0039-2499 2005-03-01 Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol602606, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69305]], camposKey:0039-2499 2005-02-01 A panel of biomarkers may successfully predict acute stroke diagnosis419419, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69299]], camposKey:0039-2499 2005-02-01 C-reactive protein predicts progression of intracranial atherosclerotic stenoses498498, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69300]], camposKey:0039-2499 2005-02-01 Differential response to thrombolysis among patients with tandem ICA/MCA occlusions449449, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69301]], camposKey:0039-2499 2005-02-01 Geno-tPA: A pharmacogenomic approach to identifying polymorphisms modifying safety and efficacy of thrombolysis for acute stroke436437, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69304]], camposKey:0039-2499 2005-02-01 Microbubbles administration accelerates clot lysis during continuous 2 MHz ultrasound monitoring in stroke patients treated with intravenous tPA419419, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69302]], camposKey:0039-2499 2005-02-01 Safety and efficacy of intravenous tPA stroke treatment in the 3-to 6-hour window using a multimodal MRI selection protocol431432, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69303]], camposKey:0039-2499 2005-02-01 Speed of diffusion-weighted imaging lesion expansion within 3 hours from stroke onset predicts evolution to malignant MCA infarction431431, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41878]], camposKey:0039-2499 2005-01-01 Angiogenesis in symptomatic intracranial atherosclerosis: Predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence9297, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69322]], camposKey:0028-4793 2004-11-18 Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke21702178, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41879]], camposKey:0039-2499 2004-11-01 Impact of admission hyperglycemia on stroke outcome after thrombolysis: Risk stratification in relation to time to reperfusion24932498, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41880]], camposKey:0039-2499 2004-09-01 Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator21232127, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41881]], camposKey:0033-8419 2004-08-01 Hyperacute ischemic stroke: Middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging466473, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41882]], camposKey:0028-3878 2004-07-13 High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis2732, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41883]], camposKey:0340-6245 2004-06-01 Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator11461151, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41884]], camposKey:0039-2499 2004-06-01 Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: Relationship to clinical and radiological outcome13161322, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70953]], camposKey:0025-7753 2004-04-17 Clinical benefit following the implementation of a specialized urgent stroke care system528531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69314]], camposKey:1567-5688 2004-04-01 Thrombotic risk factors and silent myocardial ischemia in patients with symptomatic intracranial large-artery atherosclerosis9393, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69336]], camposKey:0210-0010 2004-03-16 Reversible segmental cerebral vasoconstriction: The value of duplex transcranial Doppler in its diagnosis and follow-up530533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41886]], camposKey:0210-0010 2004-03-16 Reversible segmental cerebral vasoconstriction: The value of duplex transcranial doppler in its diagnosis and follow-up Vasoconstricción segmentaria cerebral reversible: Utilidad del dúplex transcraneal en el diagnóstico y seguimiento530533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69339]], camposKey:0210-0010 2004-03-01 Clinical factors predicting the appearance of vascular events following a transient ischemic attack416421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41887]], camposKey:0210-0010 2004-03-01 Clinical factors predicting the appearance of vascular events following a transient ischemic attack Factores clínicos predictores de la aparición de episodios vasculares tras un ataque isquémico transitorio416421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41888]], camposKey:0039-2499 2004-02-01 Differential Pattern of Tissue Plasminogen Activator-Induced Proximal Middle Cerebral Artery Recanalization among Stroke Subtypes486490, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69316]], camposKey:0039-2499 2004-01-01 Angiogenesis in symptomatic intracranial large-artery occlusive disease: Vascular endothelial growth factor and endostatin level are related to disease severity.317317, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69317]], camposKey:0039-2499 2004-01-01 Baseline plasma PAI-1 level predicts recanalization, hemorrhagic transformation, and outcome in tPA-treated patients.292292, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47415]], camposKey:0025-7753 2004-01-01 Beneficios clínicos de la implantación de un sistema de atención especializada y urgente del ictus528531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93969]], camposKey:0210-0010 2004-01-01 Factores clínicos predictores de la aparición de episodios vasculares tras un ataque isquémico transitorio416421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69335]], camposKey:0213-4853 2004-01-01 Homocysteine in the acute phase of stroke1014, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41889]], camposKey:0213-4853 2004-01-01 Homocysteine in the acute phase of stroke Papel de la homocisteina en la fase hiperaguda del ictus1014, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69318]], camposKey:0039-2499 2004-01-01 Impact of acute hyperglycemia on stroke outcome after thrombolysis: Risk stratification in relation to time to reperfusion251251, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93961]], camposKey:0213-4853 2004-01-01 Papel de la homocisteína en la fase hiperaguda del ictus1014, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69319]], camposKey:0039-2499 2004-01-01 Predictors of early arterial reocclusion after tPA-induced recanalization250250, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69315]], camposKey:0039-2499 2004-01-01 Proteolytic modifications on the metalloproteinase system (MMP-9-laminin-TIMP-1) induced by t-PA treatment for acute cerebral ischemia in humans339339, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69320]], camposKey:0039-2499 2004-01-01 Speed of tPA-induced clot dissolution predicts the evolution of DWI abnormalities in hyperacute stroke236236, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93960]], camposKey:0210-0010 2004-01-01 Vasoconstricción segmentaria cerebral reversible: utilidad del dúplex transcraneal en el diagnóstico y seguimiento530533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41891]], camposKey:0039-2499 2003-12-01 Safety Profile of Tissue Plasminogen Activator Treatment among Stroke Patients Carrying a Common Polymorphism (C-1562T) in the Promoter Region of the Matrix Metalloproteinase-9 Gene28512855, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41892]], camposKey:0039-2499 2003-10-01 C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease24632468, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41893]], camposKey:0039-2499 2003-05-01 Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients12351240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41894]], camposKey:0009-7322 2003-02-04 Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke598603, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70954]], camposKey:0025-7753 2003-01-25 Stroke code impact on the efficacy of thrombolytic treatment4751, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69344]], camposKey:0039-2499 2003-01-01 Diurnal variation on recanalization rates after intravenous tPA for acute stroke: A multicenter study279280, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47414]], camposKey:0025-7753 2003-01-01 Impacto de la activación del Código Ictus en la eficacia del tratamiento trombolítico4751, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69343]], camposKey:0039-2499 2003-01-01 Intravenous tPA for ischemic stroke in the elderly: Safety and efficacy in routine clinical practice311311, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69345]], camposKey:0039-2499 2003-01-01 Matrix metalloproieinase (MMP-9) is related to glucose level and predicts cerebral infarct size on DWI and bleedings in tPA-treated patients278278, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41896]], camposKey:0271-678X 2003-01-01 Plasmatic Level of Neuroinflammatory Markers Predict the Extent of Diffusion-Weighted Image Lesions in Hyperacute Stroke14031407, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69347]], camposKey:0039-2499 2003-01-01 Serum glucose as a predictor of poor outcome in reperfused tPA treated patients270270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69346]], camposKey:0039-2499 2003-01-01 Serum lipoprotein (A) is a powerful marker of the extent and severity of MRA-confirmed intracranial atherosclerotic large-vessel disease270270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69348]], camposKey:0039-2499 2003-01-01 Thrombin-activable fibrinolysis inhibitor (TAFI) level is related to T-PA-induced recanalization resistance after human ischemic stroke240240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70955]], camposKey:0025-7753 2002-12-07 Hematomyelia as late side effect of radiation799799, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41897]], camposKey:0025-7753 2002-12-07 Hematomyelia as late side effect of radiation [6] Hematomielia espontánea como efecto tardío de la radioterapia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69356]], camposKey:0210-0010 2002-11-01 Study of the hypoplasic internal carotid artery by use of multislice spiral computed tomography two case reports832837, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41898]], camposKey:0210-0010 2002-11-01 Study of the hypoplasic internal carotid artery by use of multislice spiral computed tomography. Two case reports Estudio de la arteria carótida interna hipoplásica mediante tomografía computarizada helicoidal multicorte. A propósito de dos casos832837, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41899]], camposKey:0039-2499 2002-09-01 Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke21972203, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41900]], camposKey:0213-4853 2002-08-15 Chronic subdural hematoma simulating a TIA. Implications for the management transient neurological deficit Hematoma subdural crónico simulando un AIT. Implicaciones en el tratamiento del déficit neurológico transitorio342344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41901]], camposKey:0039-2499 2002-06-22 Thrombolysis-related hemorrhagic infarction: A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion15511556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70956]], camposKey:0213-4853 2002-06-01 Chronic subdural hematoma simulating a TIA. Implications for the management transient neurological deficit342344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69367]], camposKey:0039-2499 2002-01-01 Circadian variations on successful recanalization after thrombolysis in acute cardioembolic stroke371371, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69368]], camposKey:0039-2499 2002-01-01 Expansion of the hyperacute (< 6h) diffusion defect within the ischemic penumbra is an independent predictor of stroke outcome. A multivariate analysis362363, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93966]], camposKey:0025-7753 2002-01-01 Hematomielia espontánea como efecto tardío de la radioterapia7990, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69366]], camposKey:0039-2499 2002-01-01 Reperfusion injury after human cardioembolic stroke? A possible role for inflammatory mechanisms405405, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69369]], camposKey:0039-2499 2002-01-01 Thrombolysis-related hemorrhagic infarction (HI1 and HI2). A marker of reperfusion, reduced infarct size and improved outcome in patients with proximal MCA occlusion352353, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69364]], camposKey:0210-0010 2001-07-16 Correlation between the expression of proinflammatory cytokines and matrix metalloproteinases in the acute phase of an ischemic stroke115118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70959]], camposKey:0025-7753 2001-01-20 Acute phase response after stroke: differences between ischemic stroke and intracerebral hemorrhage5455, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41903]], camposKey:0025-7753 2001-01-20 Acute phase response after stroke: Differences between ischemic stroke and intracerebral hemorrhage Reactantes de fase aguda en el ictus: Diferencias entre el infarto isquémico y la hemorragia intracerebral5455, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69365]], camposKey:0039-2499 2001-01-01 Adhesion molecule (ICAM-1) serum levels are related to spontaneous recanalization in human ischemic stroke.340340, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41902]], camposKey:0210-0010 2001-01-01 Correlation between the expression of proinflammatory cytokines and matrix metalloproteinases in the acute phase of an ischemic stroke Correlación entre la expresión de citocinas proinflamatorias y metaloproteinasas de matriz en la fase aguda del ictus isquémico115118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41908]], camposKey:0039-2499 2001-01-01 Matrix metalloproteinase expression after human cardioembolic stroke: Temporal profile and relation to neurological impairment17591766, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41905]], camposKey:0039-2499 2001-01-01 Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke27622767, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41904]], camposKey:0039-2499 2001-01-01 Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: A long-term follow-up transcranial Doppler ultrasound study28982904, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81436]], camposKey:0025-7753 2001-01-01 Reactantes de fase aguda en el ictus: diferencias entre el infarto isquémico y la hemorragia intracerebral5455, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41907]], camposKey:0039-2499 2001-01-01 Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: A case-control study28212827, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41906]], camposKey:0039-2499 2001-01-01 Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke10791084, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41909]], camposKey:0213-4853 2000-12-01 High level of protein content in LCR and borderline values of intracranial pressure in a patient with benign sexual headache Hiperproteinorraquia y valores límite de presión intracraneal en un paciente con cefalea sexual benigna317318, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70957]], camposKey:0025-7753 2000-01-15 Acute bilateral ophthalmoplegia with raised anti-GQ1b antibodies3838, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41910]], camposKey:0025-7753 2000-01-01 Acute bilateral ophthalmoplegia with raised anti-GQ1b antibodies Oftalmoplejía bilateral aguda con elevación de anticuerpos anti-GQ1b.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=93965]], camposKey:0025-7753 2000-01-01 Oftalmoplejía bilateral aguda con elevación de anticuerpos anti-GQ1b3838][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=32753]},camposKey: Evidence-Based Practice and Trends in Visual Rehabilitation for Patients with Age-Related Macular Degeneration 978-1-83968-903-1Recent Advances and New Perspectives in Managing Macular Degeneration 1 2022-01-01 IntechOpen, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=32310]},camposKey: 433 454 Educational opportunities of virtual game-based initiatives for students with disabilities 1668442876Handbook of Research on the Influence and Effectiveness of Gamification in Education 1 2021-11-30 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=15768]},camposKey: 113 124 Natural Course and Prognosis 978-140517822-8Intracranial Atherosclerosis 1 2009-01-01 ][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=123464],camposKey=978-84-9110-476-6Neurosonología 1 2011-01-01 Editorial Médica Panamericana}][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64236]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62216]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63943]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64236]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62216]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63943]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=821]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=821]]][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31358]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31201]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31012]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30735]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30557]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30449]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636189]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638667]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145632712]]][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a58e5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64f473, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a5bd4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a58a1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a62a9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a513e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a63bd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a58a2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a54ba, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a659b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a6221, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a6222, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a542f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a52b9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a5249, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a5bd6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a52b7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a5904, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a51fa, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a64a7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a655f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a6598, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a649e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375207, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375258, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37d76c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a604e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a5be7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a53b3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a601b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a6017, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a6400, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a6121, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a505e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a6116, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a624c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a560c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a592a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a581e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a5a44, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a572a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a5590, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a5fb1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a512e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a5500, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6a5603][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bc684], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c1d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56fa90], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467bdf], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414ec1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c1b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125a2], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4123f4]][][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14bca][]
